68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors

<strong><em>Objective(s):</em></strong> <sup>68</sup>Ga-DOTATATE positron emission tomography (PET)/computed tomography (CT) has shown promising results in imaging of neural crest tumors (NCT). Herein, we compared the performance of <sup>68</sup>Ga-DOT...

Full description

Bibliographic Details
Main Authors:	Pezhman Shahrokhi, Alireza Emami-Ardekani, Sara Harsini, Mohammad Eftekhari, Armaghan Fard Esfehani, Babak Fallahi, Najme Karamzade Ziarati, Mehdi Akhlaghi, Saeed Farzanefar, Davood Beiki, Amir Pejman Hashemi Taheri
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2020-01-01
Series:	Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:	68ga-dotatate 131i-mibg pet/ct neural crest tumors
Online Access:	http://aojnmb.mums.ac.ir/article_14215_f10a5482f029999be216e865dfd8b6b6.pdf

Similar Items

Anatomic Patterns of Relapse and Progression Following Treatment with 131I-MIBG in Metastatic Neuroblastoma
by: Fishel Ben-Kenan, Rotem
Published: (2018)

Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)
by: Armaghan Fard-fahani, et al.
Published: (2011-09-01)

Radioterapia interna con metayodobencilguanidina 131I-MIBG
by: Harold Machado, et al.
Published: (2002-07-01)

Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors
by: Babak Fallahi, et al.
Published: (2019-06-01)

Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
by: Tarun Kumar Jain, et al.
Published: (2016-01-01)

Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
by: Jianhua Feng, et al.
Published: (2020-09-01)

Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
by: Barai Sukanta, et al.
Published: (2004-10-01)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Clinical Usefulness of 99mTc-HYNIC-TOC and 131I-MIBG Scintigraphy in the Evaluation of Adrenal Tumors
by: Vukomanovic Vladimir, et al.
Published: (2019-09-01)

Uptake and Exposure Measurements in Health Physics Technicians Associated with 131I-MIBG Patient Therapy
by: Collier, Jason L.
Published: (2016)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
by: Jonathan Gear, et al.
Published: (2020-03-01)

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of <sup>131</sup>I-MIBG
by: Ezziddin Samer, et al.
Published: (2012-01-01)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
by: Abele, J., et al.
Published: (2022)

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
by: Samuel L. Brady, et al.
Published: (2019-12-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
by: Pedro M. Rubio, et al.
Published: (2020-05-01)

131I-MIBG and neuroendocrine tumours
by: Juan Perfecto Oliva González, et al.
Published: (2012-07-01)

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
by: Camilo Jimenez, et al.
Published: (2019-07-01)

Low-dose, low-specific activity 131I-metaiodobenzyl guanidine therapy in metastatic pheochromocytoma/sympathetic paraganglioma: Single-center experience from Western India
by: Rohit Barnabas, et al.
Published: (2021-01-01)

Initial clinical evaluation of indigenous90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
by: Rahul V Parghane, et al.
Published: (2021-01-01)

The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)

Comparison of 18F‐FDG PET/CT and 68Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia
by: Hao‐nan Yu, et al.
Published: (2021-05-01)

Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
by: Thomas Blom, et al.
Published: (2021-08-01)

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
by: Madhav Prasad Yadav, et al.
Published: (2019-02-01)

Tissue dose estimation after extravasation of 177Lu-DOTATATE
by: Perrine Tylski, et al.
Published: (2021-03-01)

Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma
by: Emily B. Ambinder, MD, et al.
Published: (2020-08-01)

[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study
by: Alexandra Oudot, et al.
Published: (2021-09-01)

Efficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Halil Komek, et al.
Published: (2019-06-01)

Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India
by: Julie Hephzibah, et al.
Published: (2014-09-01)

Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
by: Hiroshi Wakabayashi, et al.
Published: (2019-06-01)

Unsuspected pheochromocytoma incidentally found on chest CT
by: Bradford Bennett, MD, et al.
Published: (2018-02-01)

Asymptomatic Presacral Paraganglioma: Management of an Unpredictable Intraoperative Finding
by: Athina A. Samara, et al.
Published: (2020-04-01)

Malignant Retroperitoneal Paraganglioma with T11 Metastasis and Compression of the Spinal Cord
by: Habibollah Mahmoodzade, et al.
Published: (2014-12-01)

Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells
by: Donna L. Nile, et al.
Published: (2021-05-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
by: Raita Araki, et al.
Published: (2018-06-01)

Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
by: Nagahisa Murakami, et al.
Published: (2019-04-01)

Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network
by: Jonathan Wehrend, et al.
Published: (2021-10-01)

Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction
by: Leandro Rocha Messias, et al.
Published: (2016-01-01)

A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
by: Sara Harsini, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_8ij5vjo3b7p3bbd9fd70ph7b0p